Avapritinib: First Approval-Reference-Cited by-同舟云学术

Avapritinib: First Approval

Published:2020-02-25 Issue:4 Volume:80 Page:433-439
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

Dhillon Sohita

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-020-01275-2.pdf

Reference19 articles.

1. Du Z, Lovly CM. Mechanisms of receptor tyrosine kinase activation in cancer. Mol Cancer. 2018;17(1):58.

2. National Comprehensive Cancer Network. NCCN clinical practice guidelines in oncology: soft tissue sarcoma (version 4.2019). 2019. https://www.nccn.org/professionals/physician_gls/pdf/sarcoma.pdf. Accessed 22 Jan 2020.

3. Evans EK, Gardino AK, Kim JL, et al. A precision therapy against cancers driven by KIT/PDGFRA mutations. Sci Transl Med. 2017;9(414):1–11.

4. Gebreyohannes YK, Wozniak A, Zhai ME, et al. Robust activity of avapritinib, potent and highly selective inhibitor of mutated KIT, in patient-derived xenograft models of gastrointestinal stromal tumors. Clin Cancer Res. 2019;25(2):609–18.

5. Blueprint Medicines Corporation. AYVAKIT (avapritinib): US prescribing information. 2020. https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212608s000lbl.pdf. Accessed 17 Jan 2020.

Cited by 73 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Avapritinib-based SAR studies unveil a binding pocket in KIT and PDGFRA;Nature Communications;2024-01-02

2. Copper pyrazole complexes as potential anticancer agents: Evaluation of cytotoxic response against cancer cells and their mechanistic action at the molecular level;Coordination Chemistry Reviews;2024-01

3. Synthetic Approaches to Piperazine-Containing Drugs Approved by FDA in the Period of 2011–2023;Molecules;2023-12-21

4. KIT Mutations and Other Genetic Defects in Mastocytosis;Immunology and Allergy Clinics of North America;2023-11

5. KIT/PDGFR/Multikinase Inhibitors;Molecules Engineered Against Oncogenic Proteins and Cancer;2023-09-08